These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2063416)

  • 1. Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents.
    Eugui EM; Mirkovich A; Allison AC
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):15-8. PubMed ID: 2063416
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
    Allison AC; Almquist SJ; Muller CD; Eugui EM
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of RS-61443 on antibody-mediated rejection.
    Knechtle SJ; Wang J; Burlingham WJ; Beeskau M; Subramanian R; Sollinger HW
    Transplantation; 1992 Mar; 53(3):699-701. PubMed ID: 1549873
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice.
    Eugui EM; Mirkovich A; Allison AC
    Scand J Immunol; 1991 Feb; 33(2):175-83. PubMed ID: 2017655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.
    Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of both MLC and in vitro IgG memory response to tetanus toxoid by RS-61443.
    Burlingham WJ; Grailer AP; Hullett DA; Sollinger HW
    Transplantation; 1991 Feb; 51(2):545-7. PubMed ID: 1825249
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid.
    Nelson PH; Eugui E; Wang CC; Allison AC
    J Med Chem; 1990 Feb; 33(2):833-8. PubMed ID: 1967654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.
    Barten MJ; van Gelder T; Gummert JF; Shorthouse R; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2254-5. PubMed ID: 11377519
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.
    Morris RE; Wang J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):493-6. PubMed ID: 1990597
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of immunosuppression by lymphocyte functions in human blood.
    Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF
    Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.
    Izeradjene K; Quemeneur L; Michallet MC; Bonnefoy-Berard N; Revillard JP
    Transplant Proc; 2001 May; 33(3):2110-1. PubMed ID: 11377468
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
    Hullett DA; Sollinger HW
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):45-7. PubMed ID: 8516943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive and long-acting anti-inflammatory activity of mycophenolic acid and derivative, RS-61443.
    Allison AC; Eugui EM
    Br J Rheumatol; 1991; 30 Suppl 2():57-61. PubMed ID: 1993259
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays.
    Barten MJ; Gummert JF; van Gelder T; Shorthouse R; Morris RE
    Transplant Proc; 2001 May; 33(3):2119-20. PubMed ID: 11377470
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of RS-61443 on pancreatic islet xenografts.
    Beger C; Vajkoczy P; Menger MD; Messmer K
    Transplant Proc; 1994 Apr; 26(2):759. PubMed ID: 8171650
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 19. DAB486-IL-2 (IL-2-toxin) in combination with low-dose RS-61443 (mycophenolate mofetil) prolongs murine thyroid allograft survival.
    Hullett DA; Landry AS; Eckhoff DE; Nichols JC; Eugui EM; Allison AC; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):756-7. PubMed ID: 8438470
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and DAB486 IL-2.
    Grailer A; Nichols J; Hullett D; Sollinger HW; Burlingham WJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):314-5. PubMed ID: 1990540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.